LACAX
Price
$10.60
Change
+$0.10 (+0.95%)
Updated
Jun 22 closing price
Net Assets
2.75B
VMGMX
Price
$132.08
Change
+$0.31 (+0.24%)
Updated
Jun 22 closing price
Net Assets
33.76B
Interact to see
Advertisement

LACAX vs VMGMX

LACAX vs VMGMX Comparison Chart in %
View a ticker or compare two or three
VS
LACAX vs. VMGMX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LACAX is a Hold and VMGMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.8B vs. LACAX (2.75B). VMGMX pays higher dividends than LACAX: VMGMX (0.62) vs LACAX (0.00). LACAX was incepted earlier than VMGMX: LACAX (26 years) vs VMGMX (15 years). LACAX (1.10) is less costly to investors than VMGMX (0.07). LACAX is a more actively managed with annual turnover of: 78.00 vs. VMGMX (17.00). LACAX has a lower initial minimum investment than VMGMX: LACAX (2000) vs VMGMX (3000). LACAX annual gain was more profitable for investors over the last year : 32.24 vs. VMGMX (11.76). VMGMX return over 5 years is better than : 31.10 vs. LACAX (-16.90).
LACAXVMGMXLACAX / VMGMX
Total Expense Ratio1.080.071,543%
Annual Report Gross Expense Ratio1.100.071,571%
Fund Existence26 years15 years-
Gain YTD17.4509.952175%
Front Load6%N/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets2.75B33.8B8%
Annual Yield % from dividends0.000.62-
Returns for 1 year32.2411.76274%
Returns for 3 years51.5255.5393%
Returns for 5 years-16.9031.10-54%
Returns for 10 years-30.37213.13-14%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMUX22.59N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
MRICX26.84N/A
N/A
MFS Research International C
ICSSX16.85N/A
N/A
VY® Columbia Small Cp Val & InflectionS
ALVDX11.09N/A
N/A
American Century Focused Lg Cap Val R6
BRUMX18.35N/A
N/A
MFS Blended Research Value Equity R4